Watch Open Online Ivermectin Conference: April 24-25 2021

Medical experts from around the world will join together to present the very latest real world research on repurposing this safe drug  that has the ability to transform global efforts to fight the pandemic.

Topics include:

  • Mechanism of IVM for covid-19
  • Protocols for prevention and treatment
  • Treating Long Covid with IVM
  • Weight of Evidence with real world data
  • Up to the minute reports on trials
  • IVM for the elderly

Speakers

Dr Mobeen Syed, Dr Tess Lawrie, Prof. Pierre Kory, Prof. Hector Carvallo, Mr. Juan Jose Chamie Quintero, Mr Andrew Bryant, Dr. David Chesler, Prof. Eli Schwartz, Dr Wasif Khan,  Dr. Manjul Medhi, Prof. Matjaž Zwitter. More info on speakers >>

Please note that speakers and timings are subject to change.

Programme

Speaker time slots allow for 10 minutes of questions at the end of the slot

Day 1 – 24 April. Chair: Dr. Mobeen Syed

2pm to 6pm GMT      Start times: New York 10am, South Africa 4pm, Sydney 12 am, Lima 9am

14:00 – 14:30

1. What is ivermectin and how does it work?

Dr. Mobeen Syed provides an overview of ivermectin and how it works against covid-19.

30 minutes

14:30 – 15:15

2. Ivermectin evidence update

Dr. Tess Lawrie presents the latest systematic review evidence from RCTs and a selection of resource, equity, acceptability and feasibility considerations related to ivermectin use.

45 minutes

15:15-15:45 Break

15:45 – 16:30

3. Real world data

Mr. Juan Jose Chamie Quintero presents the latest real world data from countries using ivermectin, including the European data.

16:30 – 16:45 Break

16:45 – 17:15

4. Ongoing Trials

Mr. Andrew Bryant provides an overview of ongoing trials and what they may add to the evidence.

17:15 – 17:45

5. Ivermectin use in the elderly

Dr. David Chesler shares his experience of using ivermectin to prevent and treat covid-19 infection amongst care home residents.

17:45 – 18:00

6. Summary of 1st day by Dr. Mobeen Syed

Day 2 – 25 April. Chair: Dr. Mobeen Syed

2pm to 6:15pm GMT

14:00 – 14:30

1. Recent findings from the Israeli trial of ivermectin versus placebo

Prof. Eli Schwartz shares data and conclusions from his Israeli RCT of ivermectin in mild to moderate covid-19. 30 minutes

14:30 – 15:00

2. Protocols for prophylaxis and treatment of acute covid-19

Prof. Pierre Kory discusses current protocols for covid-19 prevention and treatment. 30 minutes

15:00 – 15:30   Break

15:30 – 16:00

3. Experiences with ivermectin in Bangladesh

Dr. Wasif Khan presents his published ivermectin trial and his experience with using ivermectin in Bangladesh. 30 minutes

16:00 – 16:30

4. Experience with ivermectin and long covid in South America.

Prof. Héctor Carvallo shares his experiences with using ivermectin for long covid. 30 minutes

Followed by a short presentation by Dr Tina Peer, UK GP who will describe her real world experiences treating Long Covid

16:30 – 17:00 break

17:00-17:30

5. Experiences of a frontline Infectious Diseases doctor in Scotland

Dr. Manjul Medhi shares his experience of using ivermectin for covid-19 in NHS Scotland. 30 minutes

17:30 – 18:00

6. Medical ethics and ivermectin

Prof. Matjaž Zwitter presents current ethical issues around ivermectin for covid-19. 30 minutes

18:00 – 18:15

7. Summary and closing statement by Dr. Mobeen Syed.

Our Speakers

Dr Héctor Carvallo

Nati Professor, Universidad Abierta Interamericana – Argentina Ivermectine and Carrageenan in the Prevention of COVID-19

Dr. Pierre Kory, MD, MPA

Board Certified in Internal Medicine, Critical Care, and Pulmonary Medicine. He is the former Chief of the Critical Care Service and Medical Director of the Trauma and Life Support Center while an Associate Professor at the University of Wisconsin.  Prior to this, he served as  the Program Director of a Pulmonary and Critical Care Fellowship Training Program at Mount Sinai Beth Israel in New York City. Dr. Kory is also considered a pioneer and national/international expert in critical care ultrasound and is the senior editor of a best-selling textbook on the subject which is in its 2nd edition and has been translated into 5 languages and has won the Presidents Choice Award from the British Medical Association in 2015. Dr. Kory   also considered a master educator and has won multiple major Departmental Teaching Awards at each institution that I have served as Faculty.

 

Dr. Kory has travelled across multiple states in the US to care for COVID-19 patients throughout the pandemic and is also the President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance, a non-profit organization of critical care specialists led by Professor Paul Marik whose mission over the past 9 months has been focused on the research and development of effective treatment protocols for COVID-19 using repurposed drugs. Most recently, based on his extensive research over the past 6 months, he has become one of the most sought-after experts on the use of ivermectin in the prevention and treatment of COVID-19.

Dr David Chesler

Internal Medicine Physician, private practice. Charlottesville Family Medicine 1980-Present. Diplomate of American Board of Internal Medicine. Board Certified in Geriatric Medicine

Prof. Matjaž Zwitter, MD, PhD

Head of the Department of Medical Ethics and Law, Medical Faculty, University of Maribor, Slovenia. His two papers on ivermectin for Covid-19, as published in Slovenian medical journal Isis and in leading newspaper Delo stirred a vivid debate among medical and lay community, hopefully leading to a change in current medical practice.

He was co-editor of two books on communication:  Communication with the cancer patient: information and truth (The New York Academy of Sciences 1997) and New challenges in communication with cancer patients ( Springer 2013). He also wrote and published three books: Talking about medical ethics (in Slovenian language, Cankarjeva založba 2018), Medical Ethics in Clinical Practice (Springer 2019) and Talking on euthanasia (in Slovenian language, Slovenska matica 2019).

Dr Wasif Khan

Enteric and Respiratory Infections. Infectious Diseases Division (IDD).  International Centre for Diarrhoeal Disease Research, Bangladesh (icddr, b).   Bangladesh Clinical Trials Limited (BCTL)

Register Now

We need your help to continue our work to get ivermectin approved in the UK and worldwide. 

Your donations will go towards the following expenses:

– E-BMC running costs:  currently two staff working full-time and one part-time on ivermectin research and education.

– Public education and awareness raising through the BIRD initiative, e.g. creating a website, responding to queries, interviews, press outreach, government lobbying.

– Expert opinion fees: e.g. statistician, regulatory authorities consultants, legal, clinical trial experts.
– Planning proposal for a trial of ivermectin to treat long-covid
– Planning further covid-19 related public health research
– Other expenses, e.g. MHRA application costs if necessary

Thank you kindly for your support.

REGISTER FOR THE EVENT WITH THIS LINK:

https://bird-group.org/conference-programme/

Disclaimer: Nothing on this Website provides medical advice or any form of diagnosis or treatment of any kind to web users. Medical decisions should be made by the patient’s physician who can consider a review of the BIRD materials and knowledge of the patient’s medical history and condition. All information provided on the BIRD website or in connection with the Website are offered to promote consideration by trained health care professionals of possible treatments and for general informational purposes and are not medical advice to users. Errors and Omissions excepted.

More at bird-group.org

Please Donate Below To Support Our Ongoing Work To Expose The Lies About COVID19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Please DONATE TODAY To Help Our Non-Profit Mission To Defend The Scientific Method.

Trackback from your site.

Comments (1)

  • Avatar

    Sherrie

    |

    Is there someplace that we would be able to view these presentations after the scheduled dates, as I’m unavailable for those particular dates but would love to hear these speakers.

    Reply

Leave a comment

Save my name, email, and website in this browser for the next time I comment.
Share via